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HIV seroadaptive behaviours may have contributed 
to greater sexually transmitted infection (STI) trans-
mission in HIV-positive men who have sex with men 
(MSM) and to the global increase in STIs. Using mul-
tiple national surveillance data sources and popu-
lation survey data, we estimated the risk of STIs in 
HIV-positive MSM and assessed whether transmis-
sion in HIV-positive MSM has contributed to recent 
STI epidemics in England. Since 2009, an increasing 
proportion of STIs has been diagnosed in HIV-positive 
MSM, and currently, the population rate of acute bac-
terial STIs is up to four times that of HIV-negative or 
undiagnosed MSM. Almost one in five of all diagnosed 
HIV-positive MSM in England had an acute STI diag-
nosed in 2013. From 2009 to 2013, the odds of being 
diagnosed with syphilis increased from 2.71 (95% con-
fidence interval (CI) 2.41–3.05, p<0.001) to 4.05 (95% 
CI 3.70-4.45, p<0.001) in HIV-positive relative to HIV-
negative/undiagnosed MSM. Similar trends were seen 
for gonorrhoea and chlamydia. Bacterial STI re-infec-
tion rates were considerably higher in HIV-positive 
MSM over a five-year follow-up period, indicative of 
rapid transmission in more dense sexual networks. 
These findings strongly suggest that the sexual health 
of HIV-positive MSM in England is worsening, which 
merits augmented public health interventions and 
continued monitoring.
Introduction
The United Kingdom (UK) has seen a steady increase 
in diagnoses of sexually transmitted infections (STIs) 
in the last decade, in particular, in men who have sex 
with men (MSM). From 2012 to 2013, gonorrhoea and 
syphilis diagnoses in MSM increased by 26% and 
12% respectively [1]. The emergence of resistance and 
reduced sensitivity to frontline treatments of gonor-
rhoea is of global concern and may have contributed to 
high levels of gonorrhoea transmission in MSM [2-4]. 
Additionally, outbreaks of less common STIs such as 
Lymphogranuloma venereum (LGV) [5], together with 
shigellosis (which can be sexually transmissible) [6] in 
this population are of particular concern.
There is increasing evidence that HIV-positive MSM in 
the UK are disproportionately affected by STIs. Recent 
data demonstrated that of MSM diagnosed with syphi-
lis, 35% were HIV positive [7]. HIV-positive MSM have 
also been found to account for more than 80% of LGV 
cases [5]. In part, these observations may reflect sero-
adaptive behaviours in HIV-positive MSM [8], in which 
different sexual practices such as unprotected (i.e. con-
domless) anal intercourse are adopted according to the 
reported HIV status of both partners in order to reduce 
the risk of transmitting or acquiring HIV. Seroadaptive 
behaviours vary considerably and include serosorting 
(limiting sexual partners to those with the same HIV 
status as themselves), strategic positioning (adopting 
a specific sexual position according to the HIV status 
of one’s partner), withdrawal before ejaculation, and 
negotiating around viral load [9]. However, seroadap-
tive behaviours may come at a cost of increased trans-
mission of STIs [10-12].
The UK has a growing population of HIV-positive 
MSM [13] and recent studies suggest that they may 
be increasingly adopting seroadaptive behaviours 
[8,14]. In this study we used multiple surveillance data 
sources and population survey data to estimate the 
risk of STIs in HIV-positive MSM and assessed whether 
transmission in HIV-positive MSM has contributed to 
recent STI epidemics in England.
Methods
Sources of data
Descriptive and comparative data analyses of the 
incidence of STIs were undertaken using data from 
GUMCADv2 (Genitourinary Medicine Clinic Activity 
Dataset) [15]. The Survey of Prevalent HIV Infections 
Diagnosed (SOPHID) [16], the third National Survey 
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of Sexual Attitudes and Lifestyles (Natsal-3) [17] and 
census data from the Office for National Statistics 
(ONS) [18] were employed to estimate denominator 
populations.
GUMCADv2 is a mandatory electronic pseudo-
anonymised (i.e. contains the sex, age and hospital/
clinic number of each patient but no patient identifi-
able information such as name, date of birth or post-
code of residence is included) [19] patient-level dataset 
submitted to Public Health England (PHE) by all genito-
urinary medicine (GUM) clinics in England. The dataset 
contains information on all STI diagnoses and services 
provided for each patient as well as information on 
patient demographic such as sexual orientation, age, 
sex, ethnicity, area of residence and country of birth 
[19]. A unique patient identifier is assigned to each 
patient attending a given GUM clinic, allowing subse-
quent visits by the same patient to the same clinic to 
be identified.
SOPHID is a cross-sectional survey of all persons with 
diagnosed HIV infection who attend for HIV care at an 
NHS site in England, Wales and Northern Ireland. Age, 
sex, probable route of HIV infection, ethnicity, antiret-
roviral therapy (ART) status, CD4 cell count, region of 
residence and region of care provider are measured for 
each calendar year.
Natsal-3 is a nationally representative survey con-
ducted between 2010 and 2012 on 15,162 individuals 
and provides information on key sexual behaviours, 
risk factors and also includes biological sampling and 
testing.
ONS is the national statistical institute for the UK and 
is responsible for collecting and publishing statistics 
related to the economy, population and society at 
national, regional and local levels.
Study population
MSM were defined as men who reported a homosexual 
or bisexual orientation at least once over the study 
period. MSM were defined as diagnosed HIV positive 
(hereafter referred to as ‘HIV-positive’ MSM) if they 
were diagnosed with HIV at least six weeks before their 
STI diagnosis, as newly diagnosed with HIV if they were 
diagnosed within six weeks of their STI diagnosis, and 
as HIV-negative/undiagnosed if there was no evidence 
of an HIV diagnosis in their GUMCADv2 record. For the 
analysis of acute STIs, STI population rates and associ-
ation between STI outcomes and HIV status, MSM with 
new HIV diagnoses were grouped with those of nega-
tive or unknown status and referred to collectively as 
‘HIV-negative/undiagnosed’, as the newly diagnosed 
men were assumed to be undiagnosed at the time of 
their STI exposure.
Data analysis
Acute sexually transmitted infections in known 
HIV-positive men who have sex with men
Episodes of acute STI diagnoses including gonorrhoea 
(acute and complicated), syphilis (primary, second-
ary and early latent), chlamydia, genital warts (first 
episode) and genital herpes (first episode) and HIV 
status in MSM were identified using Sexual Health 
and HIV Activity Property Type (SHHAPT) codes from 
GUMCADv2 for the years 2008 to 2013. Acute gonor-
rhoea includes all new cases of uncomplicated gon-
orrhoea of the lower genitourinary tract, anorectum, 
mouth, throat and adult conjunctivitis; complicated 
gonorrhoea includes all upper genitourinary tract com-
plications (such as pelvic inflammatory disease and 
epididymitis) and systemic complications [20]. The 
proportion of STI diagnoses which were in HIV-positive 
MSM was calculated for each STI by year.
Sexually transmitted infection population rates 
in HIV-negative/undiagnosed and HIV-positive 
men who have sex with men
The rates of acute bacterial (gonorrhoea, chlamydia 
and syphilis) and acute viral STIs (first episode of 
genital warts and first episode of genital herpes) in 
HIV-positive and HIV negative/undiagnosed MSM were 
compared from 2009 to 2013. The numerators were 
individual HIV-positive and negative/undiagnosed 
MSM presenting at GUM clinics each year using data 
from GUMCADv2. The denominator for HIV-positive 
MSM was identified from SOPHID. The proportion of 
men aged 15 to 74 years who are MSM was estimated 
using data from Natsal-3. An estimated 2.6% of men in 
the UK had at least one male sexual partner in the past 
five years across all age groups of men [21]. This was 
applied to the mid-year population estimates from the 
ONS for the number of men aged 15 to 74 years for each 
year [22,23], and the estimated number of HIV-positive 
MSM was subtracted from this to calculate the denomi-
nator for HIV-negative/undiagnosed MSM. The results 
of a sensitivity analysis (data not shown) showed a 
small effect when using the upper and lower limits of 
the confidence interval (2.1% and 3% respectively) of 
the estimation of men in the UK having at least one 
male sexual partner in the past five years across all 
ages of men. For the most recent year of analysis, the 
range for bacterial STIs in HIV-negative MSM was 33 
per 1,000 to 48 per 1,000.
Associations between sexually transmitted 
infection outcomes and HIV status
Univariate and multivariate logistic regression models 
were prepared for the MSM population attending GUM 
clinics in England for each individual MSM diagnosed 
with an acute bacterial STI (gonorrhoea, chlamydia 
and syphilis) for each year from 2009 to 2013 inclu-
sive. Explanatory variables included all demographic 
variables from GUMCADv2 (age, ethnicity, continent 
of birth, and area of residence), diagnosed HIV status, 
and number of tests in the previous 12-month period 
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for each respective bacterial STI; all were included in 
the final multivariate model.
Gonorrhoea and chlamydia re-infection rates 
by HIV status
The probability of patients who became re-infected 
with the most common bacterial STIs (gonorrhoea 
and chlamydia) within one year was estimated by the 
Kaplan-Meier method. Patients became at-risk from 42 
days after the time of first attendance with gonorrhoea 
and chlamydia [24] and were censored at the end of the 
study period (31 December 2013). Data for calculating 
re-infection rates was obtained from GUMCADv2.
All statistical analyses were undertaken using Stata 
version 12 (StataCorp, College Station, Texas, US). 
P values < 0.05 were considered to be statistically 
significant.
Results
During the study period, the number of MSM attend-
ing GUM clinics recorded in GUMCADv2 increased from 
78,226 in 2009 to 117,410 in 2013. The total number of 
MSM attendances increased from 241,676 to 316,250. 
The number of MSM in England estimated using 
Natsal-3 and ONS was 501,895 in 2009, increasing to 
516,416 in 2013.
Acute sexually transmitted infections in known HIV-
positive men who have sex with men
The proportion of acute STI diagnoses in MSM that 
were in HIV-positive MSM is shown in Figure 1. Overall, 
from 2009 to 2013, this proportion increased for all 
acute STIs: from 25% to 40% for syphilis, 16% to 25% 
for chlamydia, 15% to 24% for gonorrhoea, 19% to 21% 
for genital herpes and 7% to 10% for genital warts.
Sexually transmitted infection population rates 
in HIV-negative/undiagnosed and HIV-positive 
men who have sex with men
The rate of acute bacterial STIs in HIV-positive MSM 
nearly trebled (64 per 1,000 to 161 per 1,000), and 
increased from 3.2 times higher than the rate in HIV-
negative/undiagnosed MSM in 2009 to 4.2 times higher 
in 2013 (Figure 2). For HIV-negative/undiagnosed MSM, 
the rate of acute bacterial STIs also increased to a 
lesser degree (19 per 1,000 to 38 per 1,000). The rate of 
acute viral STIs in HIV-positive MSM was approximately 
twice that observed in HIV-negative/undiagnosed MSM 
and remained fairly stable over the five year period (15 
to 18 per 1,000 in HIV-positive and 8 to 9 per 1,000 in 
negative/undiagnosed MSM). This indicates that the 
rate of acute STIs in HIV-positive MSM was close to one 
in five (179 per 1,000).
Figure 1
Proportion of acute sexually transmitted infection diagnoses in men who have sex with men which were in HIV-positive 
men who have sex with men, England, 2009–2013
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Associations between sexually transmitted 
infection outcomes and HIV status
Table 1 shows the final multivariate logistic regres-
sion models for gonorrhoea, chlamydia and syphilis 
adjusted for all explanatory variables. Data are pre-
sented for the most recent available year only. Table 2 
shows the change in the adjusted odds ratio over time 
by HIV status. When compared with HIV-negative/undi-
agnosed MSM, the adjusted odds ratio (aOR) of being 
diagnosed with gonorrhoea, chlamydia and syphilis 
was significantly higher in HIV-positive MSM in all 
years analysed and increased over time (p<0.001).
Gonorrhoea and chlamydia re-infection rates 
by HIV status
The estimated probability of gonorrhoea and chlamydia 
re-infection is shown in Figure 3. A total of 34,090 and 
31,206 MSM diagnosed with gonorrhoea and chla-
mydia respectively were included. The probability 
of repeat infection with gonorrhoea was estimated 
at 36.6% in HIV-positive, 33.2% in newly diagnosed 
and 22.7% in HIV-negative/undiagnosed MSM at the 
end of the 5 year follow-up period. For chlamydia, the 
estimated probability of repeat infection was 31.6% in 
HIV-positive, 23.7% in newly diagnosed and 17.3% in 
HIV-negative/undiagnosed MSM over the same period.
Discussion
For the first time, we have estimated the relative con-
tribution of HIV-positive MSM to STI transmission over 
time in England. Since 2009, an increasing proportion 
of STIs has been diagnosed in HIV-positive MSM, and 
currently, the population rate of acute bacterial STIs is 
up to four times that of HIV-negative or undiagnosed 
MSM. We estimate that almost one in five of all diag-
nosed HIV-positive MSM in England had an acute STI 
diagnosed in 2013. The odds of being diagnosed with 
gonorrhoea, syphilis and chlamydia were significantly 
higher in HIV-positive relative to HIV-negative/undi-
agnosed MSM and increased over time. Re-infection 
rates of bacterial STIs were also considerably higher 
in HIV-positive MSM over a five-year follow-up period, 
indicative of rapid transmission in more dense sexual 
networks.
Figure 2
Rates of acute bacterial and acute viral sexually transmitted infections in HIV-positive and negative/undiagnosed men who 
have sex with men per 1,000 men who have sex with men, England, 2009–2013
MSM: men who have sex with men; STI: sexually transmitted infection.
Bacterial STIs: gonorrhoea, chlamydia and syphilis
Viral STIs: first episode of genital warts and first episode of genital herpes
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These findings strongly suggest that the sexual 
health of HIV-positive MSM in England is worsening. 
They are consistent with data from a cross-sectional 
survey of men in commercial gay venues in London, 
Brighton, Manchester, Glasgow and Edinburgh which 
demonstrated that numbers of STIs diagnosed in the 
previous 12 months were higher in MSM known to be 
HIV-infected compared with uninfected men (aOR 7.2, 
95% CI 4.63–11.17) [25], and similar studies in Europe 
[26,27]. A study of LGV re-infection in the UK also found 
that, at baseline, repeaters were more likely to be HIV-
positive compared with non-repeaters [28].
It seems probable that these changes in STI transmis-
sion patterns in HIV-positive MSM reflect increasing 
adoption of HIV seroadaptive behaviours and their 
impact on sexual network structures. HIV-positive 
MSM reporting seroadaptive behaviours are at higher 
risk of STIs compared with HIV-negative MSM [10-12]. 
One study reported that HIV-positive MSM practising 
seroadaptive behaviours had a threefold increased risk 
of bacterial STIs, with almost a third of HIV-positive 
MSM reporting an STI in the past year, compared with 
9% of HIV-negative MSM [11]. However, despite the con-
siderable changes in STI transmission patterns in HIV-
positive MSM seen in our study, the degree to which 
transmission in HIV-positive MSM engaging in seroa-
daptive behaviours is fuelling current STI epidemics in 
England is unclear. The recent emergence of relatively 
rare infections such as LGV and S. flexneri in the UK 
has been strongly and predominantly associated with 
transmission in HIV-positive MSM [5,6,29]. Likewise for 
syphilis, our study showed that 39.1% of cases in MSM 
in England were known to be HIV-positive, and this is 
consistent with data from the United States, Australia 
and Europe [26,27,30,31]. The duration of infectious-
ness with Shigella, LGV and syphilis may be short as 
these infections are typically symptomatic, so it is 
highly likely that their transmission is being sustained 
in highly active sexual networks of HIV-positive MSM 
engaging in seroadaptive behaviours [32]. However, 
fewer than 25% of MSM diagnosed with chlamydia 
and gonorrhoea (and even less with viral STIs) in our 
study were HIV-positive. Therefore, while seroadap-
tive behaviours in HIV-positive MSM may be making 
an important contribution to the transmission of chla-
mydia, gonorrhoea and viral STIs in MSM, they are not 
necessary to sustain infection at endemic levels in the 
wider MSM population.
HIV seroadaptive behaviours will likely have other 
negative or unintended consequences for the sexual 
health of MSM. The presence of an STI may compro-
mise the health of HIV-positive MSM through several 
mechanisms including a reduction in CD4 cell count as 
well as acute increases in HIV viral load, which may 
compromise effective antiretroviral therapy [33-35]. 
In addition, STIs may also increase HIV infectious-
ness by facilitating HIV shedding in the genital tract or 
rectal mucosa [36]. Further, evidence suggests that a 
low viral load may reduce the probability of infecting 
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a sexual partner [37-39], thus, HIV-positive MSM may 
engage in seroadaptive behaviours when they receive 
highly active antiretroviral therapy (HAART) or have 
an undetectable viral load. However, surveys of gay 
commercial venues and gyms in London, Glasgow and 
Edinburgh suggest the proportion of MSM reporting 
unprotected anal intercourse with partners of unknown 
or discordant HIV status has increased, leading to risk 
of HIV as well as other STI transmission [8,14].
A study by Fox et al. showed significant reduction in 
self-reported HIV transmission-risk behaviour in MSM 
recently diagnosed with HIV, with patients reporting 
greater condom use and fewer sexual partners [40]. 
However, these may have limited impact on STI inci-
dence due to the various routes of transmission of STIs 
(such as oral, digital and use of sex toys). Furthermore, 
in MSM recently diagnosed with HIV, those report-
ing continued transmission-risk behaviour were more 
likely to have another STI [40]. Thus, health promo-
tion activities should also consider the broader con-
text around sexual risk-taking in MSM, especially in 
those diagnosed with HIV. The recent Public Health 
England framework for promoting the health and well 
being of MSM highlighted the interaction of mental 
health, alcohol and drug use, and sexual risk behav-
iour [41]. There is increasing concern on the interaction 
between drug use and STIs, especially in HIV-positive 
Figure 3
Estimated probability of repeat gonococcal infection (A) and of repeat chlamydial infection (B) in men who have sex with 
men attending genitourinary medicine clinics by HIV co-infection, England, 2009–2013
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MSM, and that in developing appropriate interventions 
and services, the specific needs of HIV-positive MSM 
should be considered [29]. Furthermore, the high inci-
dence of asymptomatic STIs, especially in extra-genital 
sites [42,43] emphasises the need to promote regular 
screening for STIs in HIV-positive individuals [44,45]. 
Nonetheless, surveys of healthcare providers in the US 
have reported significant barriers, especially in screen-
ing for gonorrhoea and chlamydia, which include time 
constraints, difficulty obtaining a sexual history, lan-
guage and cultural barriers, and patient confidentiality 
concerns [46].
There are several limitations of this study. There may 
be a degree of ascertainment bias in the assessment 
of HIV status in MSM in patients with a longer his-
tory in GUMCADv2. However, sensitivity analysis (data 
not shown) was performed by identifying HIV-positive 
MSM from a retrospective review of a single year of 
GUMCADv2 data, and there was only a minimal impact 
on the results. The probability of repeat infection 
may also have been underestimated as, in this analy-
sis, repeat diagnosis was used as a proxy measure 
for repeat infection. Some patients will have become 
re-infected but will remain undiagnosed, as only 
patients who returned to the same clinic for testing 
were assessed in the analysis. This is a limitation of 
GUMCADv2, as it allows only longitudinal patient data 
within a particular clinic or service and attendances by 
the same patient at different clinics cannot be moni-
tored [19]. However, the data quality and completeness 
of GUMCADv2 is extremely high with 100% submis-
sions from GUM clinics [19]. HIV-positive MSM engaged 
in care are also more likely to return regularly for STI 
screening during clinic visits and this may have con-
tributed to the proportion and rates of STIs observed. 
Diagnosis of STIs (including HIV) is dependent on 
screening practices and frequency of screening. It is 
therefore not a true measure of incidence of infection 
but provides a good proxy for infection. A further limi-
tation is the estimation of the true size of the MSM pop-
ulation in the UK. However, the methodology employed 
in Natsal-3 is among the most robust to estimate the 
size of this population. Furthermore, between Natsal-2 
and Natsal-3, there was no significant increase in the 
proportion of men reporting same sex partners in the 
past 5 years [21]. Thus, the results of this longitudinal 
data analysis provide valuable insights into the com-
plexity and evolution of STI epidemics in England.
The presence of an increasing proportion and rates of 
acute STIs in HIV-positive MSM, a population which 
also has higher rates of repeat infection and reports 
higher risk sexual behaviour, presents an increased 
risk for the sexual health of all MSM. This therefore 
merits public health action through improved monitor-
ing and intervention. Currently, the collection of behav-
ioural data is being piloted alongside that of clinical 
and socio-demographic data and this will allow fur-
ther insights into the impact of seroadaptive practices 
to be explored in the future. Improved public health 
interventions with a holistic approach focussing on 
promoting condom use, reducing high risk behaviour 
and increasing the frequency of STI testing in MSM 
should be a priority.
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